Chair(s): Manuel Sanchez De La Torre, Athanasia Pataka
Session type: Symposium
Athanasios G. Kaditis
Session content
Raphael Heinzer
Replay
Slides
Primary and secondary cardiovascular prevention in the context of OSA: what we know and what we need
Esther Irene Schwarz
Replay
Slides
Refika Hamutcu Ersu
Replay
Slides
The AHI does not define phenotypes responsive to adenotonsillectomy in children with snoring
Athanasios G. Kaditis
Replay
Slides
Replay
Session aims
to demonstrate the relationship between polysomnographic measures and cardiovascular or neurocognitive outcomes in adults and children with obstructive sleep apnoea (OSA) and to address therapeutic effects on these consequences (two talks about adults, two talks about children, one about diagnostic markers and another about therapeutic effects); to identify predictors of favourable responses to continuous positive airway pressure (CPAP) in relation to cardiovascular morbidity; to compare the efficacy of CPAP for primary prevention versus secondary prevention of cardiovascular disease associated with OSA; to explain why caregiver-reported symptoms and OSA-related morbidity should likely take precedence over the apnoea-hypopnoea index (AHI) when making treatment recommendations for children with snoring; to describe the clinical challenges of using the AHI as a measure for defining residual OSA after adenotonsillectomy in children with snoring.